| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
109,527 | 133,927 | 117,267 | 91,303 | 57,969 |
|
Cost of Revenue
|
-44,480 | -49,654 | -49,051 | -35,836 | -25,832 |
|
Gross Profit
|
65,047 | 84,273 | 68,216 | 55,467 | 32,137 |
| Selling, General and Administrative Expenses
|
-68,319 | -74,887 | -77,905 | -64,289 | -37,977 |
|
Research and Development Expenses
|
-2,223 | -2,102 | -2,385 | -1,336 | -915 |
|
Operating Income/Expenses
|
-70,542 | -76,989 | -80,290 | -65,625 | -38,892 |
|
Total Operating Profit/Loss
|
-5,495 | 7,284 | -12,074 | -10,158 | -6,755 |
| Total Net Finance Income/Expense
|
-2,449 | -3,577 | -4,160 | -2,789 | -1,661 |
| Net Investment Income
|
-240 | -60 | 5 | 265 | 0 |
| Irregular Income/Expenses
|
-1,719 | 3,281 | 0 | 11,694 | 0 |
|
Other Income/Expense, Non-Operating
|
664 | 73 | -33 | -49 | 0 |
|
Non-Operating Income/Expenses, Total
|
-3,744 | -283 | -4,188 | 9,121 | -1,661 |
|
Pretax Income
|
-9,239 | 7,001 | -16,262 | -1,037 | -8,416 |
|
Provision for Income Tax
|
-1,898 | -2,028 | -187 | 1,697 | -69 |
|
Net Income from Continuing Operations
|
-11,137 | 4,973 | -16,449 | 660 | -8,485 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-11,137 | 4,973 | -16,449 | 660 | -8,485 |
|
Net Income after Non-Controlling/Minority Interests
|
-11,137 | 4,973 | -16,449 | 660 | -8,485 |
|
Net Income Available to Common Stockholders
|
-11,137 | 4,973 | -16,449 | 660 | -8,485 |
|
Diluted Net Income Available to Common Stockholders
|
-11,137 | 4,973 | -16,449 | 660 | -8,485 |
| Basic EPS
|
-0.08 | 0.04 | -0.12 | 0.01 | -0.09 |
| Diluted EPS
|
-0.08 | 0.03 | -0.12 | 0.01 | -0.09 |
|
Basic Weighted Average Shares Outstanding
|
140,016.2300 | 139,531.7910 | 133,665.0750 | 119,093.6870 | 94,085.1970 |
|
Diluted Weighted Average Shares Outstanding
|
145,952.4720 | 150,042.5560 | 133,665.0750 | 126,793.3180 | 94,085.1970 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-6,790 | 10,578 | -12,102 | 1,752 | -6,755 |
|
EBITDA
|
-2,768 | 15,801 | -7,878 | 4,952 | -5,455 |
|
Normalized EBITDA
|
2,140 | 16,344 | -4,030 | 1,038 | -3,000 |
|
Normalized Income
|
-6,987.1300 | 4,917.6200 | -13,409.0800 | -6,714.6500 | -6,611.9100 |
|
Total Unusual Items
|
5,253 | -78 | 3,848 | -9,335 | 2,371 |
|
Total Unusual Items Excluding Goodwill
|
5,253 | -78 | 3,848 | -9,335 | 2,371 |
12/31/2022 - 7/1/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade